[低分子量肝素（卡比2165）预防性治疗评估的生物学标准]
[Biological criteria for the evaluation of prophylactic treatment with a low molecular weight heparin (Kabi 2165)].
作者信息
Le Querrec A, Derlon A, Deshayes J P, Lefrançois C, Sillard B, Delassus P, Viel J F, Kher A, Thomas M
机构信息
Département d'Anesthésiologie, C.H.U. Côte de Nacre, Caen.
出版信息
J Mal Vasc. 1987;12 Suppl B:99-101.
PMID:2834502
Abstract
Efficacy of a low molecular weight heparin (Kabi 2165) was compared with that of non-fractionated heparin in the prevention of abdominal surgery postoperative venous thrombosis by means of a double-blind randomized trial in 79 patients. Determination of D. dimers in these patients allowed assessment of specificity of this assay for detection of postoperative venous thrombosis.
摘要
通过一项针对79例患者的双盲随机试验，比较了低分子量肝素（卡比2165）与普通肝素在预防腹部手术术后静脉血栓形成方面的疗效。对这些患者进行D - 二聚体测定，有助于评估该检测方法对术后静脉血栓形成检测的特异性。
Zotero 插件